Related Experiment Video
Updated: Jan 11, 2026

11:16
Engineering Platform and Experimental Protocol for Design and Evaluation of a Neurally-controlled Powered Transfemoral Prosthesis
Published on: July 22, 2014
16.6K
Health economic evaluation of microprocessor and non-microprocessor controlled prosthetic knees
C E Bosman1, C K van der Sluis1, A H Vrieling1
1Department of Rehabilitation Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Canadian Prosthetics & Orthotics Journal
|November 17, 2025
Summary
Microprocessor-controlled knees (MPKs) offer improved prosthesis-related quality of life but at significantly higher costs than non-microprocessor-controlled knees (NMPKs). The short-term gains in health-related quality of life do not justify the increased expense based on Dutch willingness-to-pay thresholds.
Area of Science:
- Prosthetics and Orthotics
- Health Economics
- Rehabilitation Engineering
Background:
- Microprocessor-controlled knees (MPKs) may enhance walking ability and user satisfaction compared to non-microprocessor-controlled knees (NMPKs).
- The higher acquisition cost of MPKs raises questions about their cost-effectiveness relative to NMPKs.
Purpose of the Study:
- To conduct a cost-utility and cost-effectiveness analysis of MPKs versus NMPKs.
- To evaluate these prosthetic options from a societal perspective within the Netherlands.
Main Methods:
- Utilized the EuroQol five dimensions five levels (EQ-5D-5L) for health-related quality of life.
- Employed the Prosthesis Evaluation Questionnaire (PEQ) for prosthesis-specific quality of life.
- Calculated Incremental Cost-Utility Ratio (ICUR) and Incremental Cost-Effectiveness Ratio (ICER), comparing ICUR to the Dutch willingness-to-pay threshold.
Main Results:
- MPK use resulted in a mean increase of 0.032 Quality Adjusted Life Years (QALYs) at an additional cost of €14,626.
- The mean ICUR was €457,063 per QALY gained, significantly exceeding willingness-to-pay thresholds.
- Cost differences were primarily driven by acquisition costs, though partially offset by reduced work absence and healthcare utilization.
Conclusions:
- MPKs demonstrate potential for improved prosthesis-specific quality of life but incur substantial additional costs.
- Short-term improvements in health-related quality of life were insufficient to offset MPK costs.
- The high ICUR suggests MPKs are not cost-effective within the Dutch healthcare system's established thresholds based on this 6-month evaluation.
Keywords:
AmputationCost AnalysisCost-effectivenessKnee DisarticulationLower LimbMicroprocessor KneeMobilityProsthesesQuality of LifeQuestionnaireTransfemoral
